高级检索
当前位置: 首页 > 详情页

A Worldwide Bibliometric Analysis of Tetrandrine Research in Recent Two Decades

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Cent South Univ, Xiangya Hosp, Dept Orthoped, Changsha, Peoples R China [2]Cent South Univ, Xiangya Sch Med, Changsha, Peoples R China [3]China Japan Friendship Hosp, Dept Orthoped, Beijing, Peoples R China [4]Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Plast & Reconstruct Surg,Dept Orthoped, Hangzhou, Peoples R China [5]Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
出处:
ISSN:

关键词: bibliometric tetrandrine cancer pharmacokinetics arthritis VOSviewer RStudio

摘要:
Background: Tetrandrine has been the focus of many studies in recent years. Currently, no bibliometric study in this field has been published. This study presents a bibliometric analysis of the articles on tetrandrine research from the WOS core database during the recent two decades.Methods: Documents were retrieved for further bibliometric analysis based on the search terms: [TI = (Tetrandrine OR Sinomeninea OR Hanfangchin A) AND PY = (2000-2021)]. We used Microsoft Excel to conduct the frequency analysis, VOSviewer for data visualization, and RStudio for citation metrics and analysis. The standard bibliometric indicators such as the temporal trends and geographical distribution of publications and citations, prolific authors and co-authorship, keywords citation burst, preferred journals, top-cited articles, and important institutions were applied in this study.Results: 490 documents were retrieved from WOS core database, the retrieved document type consists of 8 categories: 425 articles, 42 meeting abstracts, 8 reviews, 7 corrections, 3 editorial material, 2 proceedings paper, 1 letter, 1 retraction. Corrections and Retractions was excluded from this investigation, the left 482 document were included for furter bibliometric analysis.Conclusion: Based on our findings, there was a continuous growth of publications on tetrandrine research for 22 years since 2000. China was the largest contributor to tetrandrine research, followed by the United States. The most influential author was Cheng Y (Natl Taiwan Univ Hosp). Acta Pharmacol Sin remained the main publication related to tetrandrine research. Chinese Academy of Sciences, is expected to be a good collaborating center in tetrandrine research. The use of tetrandrine in cancer treatment, could be the promising research subject areas to follow.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 医学
小类 | 2 区 药学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 药学
JCR分区:
出版当年[2020]版:
Q1 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Cent South Univ, Xiangya Hosp, Dept Orthoped, Changsha, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Cent South Univ, Xiangya Hosp, Dept Orthoped, Changsha, Peoples R China [5]Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)